Risk versus benefit analysis regarding the exposure of man and his environment to new chemical, physical, or. biological agents resulting from altered or new technological developments, has become a familiar phrase. It has been on the minds of scientists, public health officials or administrators, but has not resulted in technical or conceptual clarification regarding the requirements for satisfactory analysis. Different points of view on benefits to society and on willingness to take calculated risks can be heard. Individuals may be willing to take risks and enjoy the realization of having taken risks-in driving cars, flying planes, participating in certain sports, or by sticking to their pack of cigarettes a day.
Taking risks with the health of the unsuspecting public, however, is quite a different matter. The risks we shall deal with here are of the latter type, and it is up to those entrusted with safeguarding the public health to make risk/ benefit evaluations for society and the environment on the basis of information available to them. Usually such information on potential hazards of newly developed products or substances is fragmentary and woefully inadequate. It is not only a matter of research funds or time until "complete safety evaluations" will be forthcoming but a profound question of how far such safety determinations can be attempted even with all the ingenuity of science at its disposal. * Besides such anatomical differences of the tracheobronchial tree or the differences in diet, emphasis must be put on comparability of absorption, distribution in the organism, retention and elimination of the chemical to obtain the greatest degree of analogy in the risk evaluation, and possible explanations of species differences in observed response. Most critical is the comparability of metabolism of the compound which must be studied regarding all major or minor pathways, metabolic shunts, and the effects of administration of enzyme inducers (intercurrent exposures to pesticides, drugs, or food additives that may affect the enzymatic pathways). Close control of the animal colony regarding these factors may not allow any extrapolation to man, who may have developed preferential metabolic pathways due to exposure to some enzyme inducer or inhibitor. Carbon monoxide may serve as an example of an inhibitor. A detailed study of human as well as laboratory animal habits is quite essential.
The above points must be taken into consideration in the planning stage or at least in the evaluation of results. However, a very difficult problem lies in the determination of significance of negative findings, i.e., the extrapolation to a safe dose. Already in 1954, Barnes and Denz (2) grappled with this problem, determining the minimum number of animals required to control the risk of failing to observe an adverse effect. To detect with a degree of probability of 0.01 an adverse reaction occurring in 1 % of the animals, one would require a group of no less than 455 animals. This requirement has hardly been followed for the reason that the cost of experiments would become prohibitive, particularly for studies of carcinogensis because of their long duration. Exposure to still lower dosage to reach the level of human exposure becomes unmanageable and costly and still will not yield data that would give any assurance of the safety of this exposure for the total population.
The difficulties in determining a "no-adverseeffect level" in animal experiments by extrapolation have been discussed repeatedly. Bliss (3) stated that the effect of low doses was qualitatively different from that of high doses. This problem has presented real difficulties regarding the acceptance of no-adverse-effect levels for carcinogenic chemicals when concepts borrowed from radiation carcinogenesis were transposed. These suggest that a single molecule might cause a permanent change which might, together with many similar events acting cumulatively over a lifetime, produce cancer. That this is not quite so could be shown by exposing animals to low doses of a carcinogen and allowing several months time before subsequent treatments with a promoter of carcinogenesis. When the carcinogenic response was no longer as expected, it was suggested that during the time interval many of the initiated cells had disappeared or could no longer respond (4) .
Studying the events in carcinogenesis and mutagenesis goes further to prove that the reaction of carcinogens or mutagens with DNA are not irreversible events. They need not lead to the expression of mutations or cancer. Repair of genetic damage has been established for several species, from bacterial to human cells. Evidence came from studies on bacterial supersensitivity to radiation, the induction of mutator genes in bacteria (5) and from observations on patients with xeroderma pigmentosum (6) where sensitivity to sunlight resulted in skin cancers in exposed areas. These multiple cancers are due to inadequacy of the cellular DNA repair mechanisms. Such deficiencies can be induced by mutations or by exposure to a few chemicals which interfere with enzymatic activity (7) but these studies surely demonstrate that in the general population the irreversibility of a one-molecule event at the DNA level does not apply, and therefore that no-effect-thresholds must exist. It is true, of course, that exposure to chemicals that can block DNA repair mechanisms could present an extreme health hazard and must be effectively guarded against.
It should be realized that the heterogeneity of the human population and their health experiences during a lifetime present different circumstances for which the findings of toxicity in inbred strains of rodents or even randombred animals do not allow reliable extrapolation. (8) ; many others are synergistic (9) . From our point of view these synergistic interactions may be troublesome for the evaluation of environmental risks.
A familiar example of synergism can be taken from the field of flavors. It is well known that flavors change in quality on addition of common salt, but more so by addition of monosodium glutamate or the disodium salts of 5'-inosinic or 5'-guanylic acids or by maltol (10) . A different kind of synergism is encountered by cigarette smokers where the chemicals responsible for the enhanced risk, particularly to lung cancer, have not been identified but where good evidence for synergism exists (11) . In occupational cancer, synergism between carcinogenic polycyclic hydrocarbons and other components of crude oil has also been postulated to exist.
The effect of microsomal enzyme induction by environmental chemicals or drugs in altering the effectiveness or toxicity of drugs or chemicals has been studied in depth. However because of differences in rates of induction of several enzyme systems, some of them leading Environmental Health Perspectives to alternate pathways, it is not always possible to predict whether toxicity of a chemical will be reduced or enhanced, even if its metabolism is well studied and the active compound identified. For instance, metabolism by ring hydroxylation versus N-hydroxylation can be mentioned, with the former leading to innocuous products and the latter to potential carcinogens (8) .
Synergism requires a certain concentration of the interacting components. In the field of carcinogenesis, when the promoter is present at too low a concentration no synergism is observed. However it is unfortunately not true that high enough concentrations of promoters are never encountered except under laboratory conditions-witness all those, for instance, for whom moderate smoking is not feasible.
Medical progress brings with it new procedures such as the use of immunosuppression, which has already produced an increased cancer risk in the recipients (12) . Similarly, lengthening the life expectancy of man will probably result in an increased cancer risk, particularly when by synergistic action the latent period of cancer development will be shortened. Thus the aging population will have to look forward to a higher incidence of cancer as part of the price of longevity.
